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The dramatic increase in numbers of the female prison population since 1980 
has been attributed to drug offenses, increasingly punitive responses to these crimes, 
and the lack of viable treatment for these women (Bloom, 1994).  Between 1990-1  996, 
0 
the rate of women’s drug possession convictions increased by 41  % and drug 
trafficking convictions rose by 34% (U.S. Department of Justice, 1999a). A 1997 
survey of State prisoners documented that over 40% of  female inmates were under the 
influence of drugs at the time of their offense, compared to 32% of male inmates (U.S. 
Department of Justice, 1999b).  Prevalence rates for drug abuse or dependence in 
women prisoners range from 26% to 63%, and alcohol abuse or dependence rates 
range from 32% to 39% (Jordan et al.,  1996; Teplin et al.,  1996; Daniel et al., 1988). 
Current drug abuse or dependence rates range from 30% to 52%, and alcohol abuse 
or dependence rates range from 17y0  to 24% (Jordan et al., 1996; Teplin et al., 1996). 
Women inmates are five to eight times more likely to abuse alcohol than women in the  e 
general population, ten times more likely to abuse drugs and 27 times more likely to 
use cocaine (Desjardins et al.,  1992; Jordan et al., 1996; Teplin et al., 1996). 
In addition to high rates of substance use disorders (SUD) among women 
prisoners, incarcerated women report extensive histories of interpersonal violence 
(Singer et al., 1995).  An epidemiologic study of female jail detainees awaiting-trial 
found that PTSD was the most common disorder, besides SUD, with prevalence rates 
of 33.5% for lifetime PTSD and 22.3% for current PTSD (Teplin et al.,  1996).  These 
rates of PTSD among women prisoners are nearly three times the rates of PTSD 
reported in a community sample of women (Kessler et ai., 1995). 
The co-occurrence of SUD and PTSD among incarcerated women is high 
(Zlotnick, 1997); a finding that is consistent with research with community samples that  a 
have found that women with current PTSD have a 1.4 to 5.5 times higher risk for 
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comorbid SUD compared to women without PTSD (Helzer et al., 1987; Kilpatrick et al., 
1996; Kessler et al., 1995; Kulka et al., 1990).  Moreover, a dual diagnosis of PTSD 
'and  SUD is associated with a more severe course and greater criminal behavior than 
would occur with either disorder alone (Brady et al., 1994; Ouimette et al., 1997). The 
high rates of recidivism among women prisoners has been explained, in part, by the 
use of illegal substances compounded by high levels of physical and sexual abuse 
(Bloom, 1994). Thus, the use of illegal substances and interpersonal victimization 
appear to play key roles in the lives of women prisoners. 
Unfortunately, there is  _- .-  little research available  I*-  describing  P  the effectiveness of 
treatment for substance-abusing women prisoners (Henderson, 1998; Peters et ai., 
1997).  Moreover, there is a dearth of treatments that have been developed specifically 
to meet the needs of women prisoners with SUD (Prendergast & Wellisch, 1995).  The 
few programs that exist in jails and prisons are often designed using approaches first 
'developed  for male inmates (Peters et al., 1997).  Numerous authors have advocated 
the need for gender-specific substance abuse treatments for incarcerated women 
based on research findings, which have identified differential needs between male and 
female inmates (e.g., Austin et al., 1992; Henderson, 1998; Peters et al., 1997; 
Prendergast &Wellisch, 1995).  In particular, these authors have consistently stressed 
the importance of services for incarcerated women that address both drug abuse and 
victimization (i.e., sexual violence and domestic violence).  To date, no treatment that 
' 
address the specific clinical needs of incarcerated women with comorbid PTSD and 
SUD have been developed or systematically evaluated. 
* 
An existing treatment, Seeking Safety: A Cognitive-Behavioral Psychotherapy 
(SS) treatment, which is based on an integration of the literature on SUD and PTSD, is 
'currently  is the treatment with the most efficacy data for this population (Najavits, 
2002).  This appears to be a promising intervention for incarcerated women with PTSD 
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that may interfere with their recovery and place these women at risk for reoffending, 
such as impulsiveness, anger dyscontrol, and maladaptive lifestyle activities. 
SCOPE AND METHODOLOGY 
The overall goal of this study was to evaluate the initial efficacy, feasibility, and 
acceptability of “Seeking Safety (SS)” treatment in a sample of incarcerated women 
with comorbid PTSD and substance abuse.  More specifically, the aims of this study 
were to conduct an open feasibility trial of the proposed treatment in a sample of 6 
incarcerated women with SUD and PTSD, and to conduct a randomized controlled pilot 
study to evaluate the initial efficacy, feasibility, and acceptability of the proposed 
treatment as an adjunct to treatment as usual (TAU) compared to a control group (TAU) 
in a sample of 22 incarcerated women with comorbid PTSD and SUD.  Regarding the 
Orandomized study, our primary hypothesis was that, compared to the TAU condition, 
women in the SS treatment condition will have less severe drugs and alcohol use as 
well as fewer PTSD symptoms and legal problems. 
Participants were recruited from the substance abuse treatment program 
(Discovery Program) in the minimum security arm of Women’s Facility of the Adult 
Correctional Institution (ACI) in Rhode Island. All participants met DSM-IV criteria for 
PTSD within the last month as determined by the Clinician Administered Posttraumatic 
Stress Disorder Scale-I (CAPS-I) (Blake et al., 1990) and SUD within the last month 
and substance abuse or dependence prior to entering prison as determined by the 
Structured Clinical Interview for DSM-IV (SCID) (First et al., 1996). Subjects were 
excluded if they a) were actively psychotic (hallucinating or delusional) at the time of 
recruitment, b) could not understand English well enough to understand the consent 
form or the assessment instruments, and benefit from the treatment, c) were 
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diagnosed with organic brain impairment. 
Protocol: 
The first 6 participants received SS group treatment (pilot group).  The remaining 
participants were randomly assigned to either the control group (TAU) (N=lO) or 
received SS treatment (N=I2) as an adjunct to TAU (experimental group).  The 
treatment groups were conducted by clinicians who worked as substance abuse 
therapists in the Discovery Program and a clinical psychologist from Brown University. 
The SS therapists received training in delivering SS therapy from Lisa Najavits who 
developed SS treatment, and received weekly supervision for the duration of the study 
from Dr. Najavits.  Sessions were 90-minutes long and were held twice a week for 12 
weeks. 
Measures  : 
Assessments were conducted at pretreatment, posttreatment (during incarceration) and 
'6-  and 12-weeks postrelease for PTSD-related measures. Measures of severity of substance 
abuse and legal problems were given at pretreatment and the 6- and 12-weeks postrelease 
intervals.  A trained research assistant administered all measures. 
Substance Use Disorder (SUD). 
The Addiction Severitv Index (ASI) (McLellan et al.,  1992) was used to assess 
change in severity of substance abuse in the past 30 days.  The SClD module on 
substance use was used to provide a diagnosis of a SUD. Urine'drug screens were 
completed at each postrelease point to detect recent drug use.  Also, a significant 
other (SO) was contacted and interviewed to provide collateral information, at each 
postrelease period. 
Posttraumatic Stress Disorder (PTSD). 
The CAPS provided a diagnoses of PTSD as well as an assessment of the  @ 
degree of PTSD symptoms (a composite score from the CAPS of the intensity and 
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Traumatic Event History. 
At pretreatment to assess lifetime history of trauma: the Trauma History 
Questionnaire (THQ; Greene, 1995) was given which yields four frequency scores: 
physical, sexual, general disaster, and crime-related traumas. 
1  egal Problems. 
The legal composite score from the AS1 was used to assess change in criminal 
activities. The legal composite index contains information about arrests, incarcerations, 
and engagement in criminal activity since release from-p_rison.  ..  I&+-” 
Patient Satisfaction with Treatment. 
At posttreatment, participants’ view of treatment was assessed on the Helping 
Alliance Questionnaire-ll (Haq-ll; Luborky et al., 1996) and the Client Satisfaction 
Questionnaire (Attkisson & Zwick, 1982). The End-of-Treatment Questionnaire 
(Najavits, 1994) addressed patients’ perceptions of the helpfulness of treatment 
components at posttreatment. 
Therapist Assessment. 
An Adherence-Competence Scale (Najavits & Liese, 1993) assessed therapist 
performance of specific interventions and group processes, each rated on adherence 
(amount of the behavior) and competence (skillfulness of the behavior).  Ratings were 
completed by Dr. Najavits on all sessions.  She found that the therapists met at least 
adequate levels of competence and adherence. 
Data Analysis. 
Several topics were addressed:  (1) characteristics of the total participants sample 
at baseline, (2) participant satisfaction with SS treatment, (3) outcome of participants 
who received SS treatment (open trial study including participants from phase one (pilot 
study) and phase two (experimental study), and (4) outcome of participants who 
0 
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defined as degree of drugs and alcohol use as measured by the AS1 subscale for 
'severity  of alcohol and drug use, PTSD symptoms as measured by the composite score 
of the CAPS, and legal problems as measured by the AS1 subscale for legal severity. 
Topics 1 and 2 were addressed using frequency data.  Topic 3 was analyzed via 
paired t-tests. Topic 4 was analyzed using a split-plot test analyses of variance 
(ANOVA) with Time [pretreatment, posttreatment,  6-weeks postrelease, 3-months 
postrelease) X Treatment (treatment group, treatment as usual) with time as a repeated 
measure 
FINDINGS 
The sample of incarcerated women who participated in the present study had 
similar sociodemographic  and criminologic characteristics (Le,, age, ethnicity, type of 
offense, and length of sentence) to the population of incarcerated women in the 
Discovery Program at the ACI.  Sixty-seven percent of the women were Caucasian, 
32% were high school graduates, 14% were in prison for the first time, and 39% had 
committed a felon.  All of the women met criteria for drug dependence, 96% reported a 
history of sexual abuse and 100% of the women had histories of repeated trauma. 
There were no significant differences between the participants in the pilot group and 
those in the experimental group at intake in sociodemographic and criminologic 
characteristics, trauma histories, degree of PTSD symptoms, and degree of legal 
problems at intake.  Likewise, there were no significant differences between the 
treatment group and control group in these intake variables. 
a 
Satisfaction with SS Treatment. 
e 
Among the remaining women (N=15), the attendance rate among the 
Only two women (1  1  %) dropped out of treatment after session two. 
0 
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0 
which provide information on the specific aspects of SS treatment clients 
found most helpful, were rated very highly (2.50 or above). 
0 
1982), results were consistently high with the average rating of 3.45 
(scaled 1 to 4 with 4 the highest) for both therapists at the end of 
treatment. 
0 
Questionnaire41 (Luborsky et al., 1996) (scaled 1 to 6, with 6 the 
strongest alliance) showed a combined average of  4.7 for both therapists 
at the end of treatment. 
All the items on the End-of-Treatment Questionnaire (Najavits, 1994), 
0 
On every measure of client satisfaction with treatment (Attkisson & Zwick, 
Patient alliance*with treatment as measured by the Helping Alliance 
utcome of Participants who received SS Treatment 
0  Of the women who received SS treatment, there was follow-up data for 17 
woman at posttreatment, 16 at 6-weeks postrelease, and 15 at 3-months 
postrelease. 
0  At posttreatment, 53% women no longer met criteria for PTSD, at 6- 
postrelease 44% no longer met criteria for PTSD, and at 3-months 
postrelease 46% no longer met criteria for PTSD. 
0  The women who received SS treatment showed a significant decrease in 
PTSD symptoms from pretreatment to: posttreatment, 6-weeks postrelease, 
and 3-months postrelease. 
0  Within 6-weeks of postrelease, 2 (1  1  YO)  of the woman returned to prison, and 
within 3-months postrelease 6 (33%) returned to prison. 
0  Based on the self-report of substance use from the SClD and the results of 
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the urinalysis, 6 (35%) of the women reported the use of illegal substances within 3- 
months postrelease. 
e 
0  Participants showed a significant decrease in drug and alcohol use, and 
in degree of legal problems from pretreatment to 6-weeks postrelease and at 
3-months postrelease 
Comparison of Outcome Between  Participants who received SS Treatment and 
Control Group 
0 
0 
group (N=7) and the group who received the treatment (N=12) in rates of 
PTSD and in severity of PTSD symptoms at any of the follow-up periods. 
Three (30%) of the women in the control groumQRpe-d-out of the study. 
There were no significant differences in outcome between the control 
0  In the control group, only I  (1  0%) woman returned to prison within 
3 months postrelease, whereas in the treatment group 6 (50%) returned to 
prison within 3 months postrelease. 
Based on the self-report of substance use from the SClD and the 
results of the urinalysis, 5 (45%) of the 11 women in the treatment group and 
2 (33%) in the control group (N=6) reported using illegal substances. 
There were no significant differences between the two groups in use of 
illegal substances, severity of drug and alcohol use, and in degree of legal 
problems from pretreatment to 6-weeks postrelease and at 3-months 
post  release. 
DISCUSSION 
Preliminary findings from the open clinical trial showed:  1  ) initial acceptability  a 
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2) the treatment appears to be highly appealing to our target sample (there was very 
.strong  alliance and satisfaction with SS treatment and retention rate in treatment was 
high), and 3) the treatment has the potential to be helpful (treatment had some 
favorable outcomes and the women felt helped by the treatment).  In general, these 
results suggest that women prisoners are able to engage in treatment and view 
treatment  as beneficial, despite their marked impairment.  More specifically, in the 
open trial of women who received SS treatment as an adjunct to TAU, there were 
significant improvements in PTSD symptoms from pre- to posttreatment, which were 
maintained until three-months postrelease.  At ,6-weeks posttreatment, there was a 
significant decrease in severity of substance use and legal problems.  The treatment, 
however, did not reduce the recidivism rate below the existing recidivism rate for 
women within the prison setting of the study.  While the current form of SS treatment 
.appears  a promising approach for incarcerated women with PTSD and SUD, the 
expansion of SS treatment to the postrelease period may substantially improve upon 
our initial findings. 
The present study found no differences between the group that received SS 
treatment and the TAU group on any indices of interest.  One explanation is that, due to 
the small sample size in the control group, significant differences between the treatment 
and the control groups were difficult to detect and, with a 30% attrition rate in the 
control group, the control group may not have been representative of women who 
received “treatment-as -usual.”  Alternatively, since the SS treatment was an adjunct 
treatment, perhaps SS treatment did not contribute beyond the effects of the substance 
use treatment (Discovery Program) that prisoners received during incarceration. 
a 
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